RNF26 Antikörper (N-Term)

Produktnummer ABIN6992190

Dieses Anti-RNF26-Antikörper ist ein Kaninchen Polyklonal-Antikörper zur Detektion von RNF26 in ELISA und WB. Geeignet für Human und Ratte.

Kurzübersicht für RNF26 Antikörper (N-Term) (ABIN6992190)

Target: RNF26 (Ring Finger Protein 26 (RNF26))

Reaktivität: Human, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser RNF26 Antikörper ist unkonjugiert

Applikation: ELISA, Western Blotting (WB)

Produktdetails anti-RNF26 Antikörper

Bindungsspezifität: N-Term

Spezifität: RNF26 Antibody is predicted to not cross-react with other CXCR familiy members.

Aufreinigung: RNF26 Antibody is affinity chromatography purified via peptide column.

Immunogen: RNF26 antibody was raised against a peptide corresponding to 14 amino acids near the amino terminus of human RNF26.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: RNF26 antibody can be used for Western blot at 1 - 2 μ,g/mL.

Antibody validated: Western Blot in human and rat samples. All other applications and species not yet tested.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 mg/mL

Buffer: RNF26 Antibody is supplied in PBS containing 0.02 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,4 °C

Informationen zur Lagerung: RNF26 antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Details zu RNF26

Target: RNF26 (Ring Finger Protein 26 (RNF26))

Andere Bezeichnung: RNF26

Hintergrund: RNF26 Antibody: RNF26 was identified as a member of a novel C3HC5 ring finger subfamily (1). RNF26 is ubiquitously expressed in human tissues but has been found to be upregulated in several cancer cell lines including HL-60, HeLa S3, and SW480, as well as 50 % of primary gastric cancers. While the substrates of RNF26 ubiquitination have not yet been identified, the upregulation of RNF26 in several types of cancer suggest that it may serve as a target for therapeutic treatment (1).

Molekulargewicht: Predicted: 48 kDa

Observed: 50 kDa

Gen-ID: 79102

NCBI Accession: NP_114404

UniProt: Q9BY78